ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CLSD Clearside Biomedical Inc

1.69
-0.02 (-1.17%)
Mar 18 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Clearside Biomedical Inc CLSD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -1.17% 1.69 19:54:25
Open Price Low Price High Price Close Price Prev Close
1.78 1.4901 1.78 1.56 1.71
more quote information »

Recent News

Date Time Source Heading
3/18/20248:51IHNWFeaturedElevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
3/18/20248:09IHNWFeaturedProspera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation
3/18/202407:05GLOBEClearside Biomedical Appoints Victor Chong, M.D., MBA as..
3/12/202416:05GLOBEClearside Biomedical Announces Fourth Quarter and Full Year..
2/29/202407:05GLOBEClearside Biomedical to Report Fourth Quarter and Full Year..
2/08/202417:05EDGAR2Form 8-K - Current report
2/08/202416:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/07/202408:00GLOBEClearside Biomedical Announces Pricing of $15 Million..
2/01/202416:01EDGAR2Form 8-K - Current report
1/19/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202415:04EDGAR2Form 144 - Report of proposed sale of securities
12/28/202316:10EDGAR2Form 8-K - Current report
12/14/202307:05GLOBEClearside Biomedical Reports Significant Progress in ODYSSEY..
11/13/202316:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202316:10EDGAR2Form 8-K - Current report
11/13/202316:05GLOBEClearside Biomedical Announces Third Quarter 2023 Financial..
11/08/202307:05GLOBEClearside Biomedical to Participate in Fireside Chat at the..
11/07/202316:20GLOBEClearside Biomedical’s Versatile Suprachoroidal Injection..
11/03/202312:01EDGAR2Form 8-K - Current report
11/03/202312:00GLOBEBioCryst and Clearside Biomedical Enter Partnership to..
11/02/202307:05GLOBEClearside Biomedical Announces Presentations at the American..
11/01/202307:05GLOBEClearside Biomedical Completes Recruitment in ODYSSEY Phase..
10/31/202307:05GLOBEClearside Biomedical to Report Third Quarter 2023 Financial..
10/16/202307:05GLOBEClearside Biomedical Positive OASIS and Extension Study Data..
10/04/202309:00GLOBEClearside Biomedical Announces Advancement of XIPERE® in..
10/03/202316:35GLOBEClearside Biomedical to Participate in a Panel Discussion at..
9/29/202316:46EDGAR2Form 8-K - Current report
9/25/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/22/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/20/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/19/202307:05GLOBEClearside Biomedical to Participate in Panel Discussion at..
9/13/202318:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202316:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202316:11EDGAR2Form 8-K - Current report
8/14/202316:05GLOBEClearside Biomedical Announces Second Quarter 2023 Financial..
8/02/202316:30GLOBEClearside Biomedical to Participate in Upcoming Investor..
8/01/202307:05GLOBEClearside Biomedical to Report Second Quarter 2023 Financial..
7/31/202307:05GLOBEClearside Biomedical Highlights Excellent Safety Profile of..
7/20/202307:05GLOBEClearside Biomedical’s Suprachoroidal Injection Platform to..
7/17/202307:05GLOBEClearside Biomedical Announces Enrollment of Multiple..
7/11/202316:05GLOBEClearside Biomedical CEO George Lasezkay to Present at the..
7/10/202307:05GLOBEClearside Biomedical Asia-Pacific Partner Arctic Vision..
6/01/202307:05GLOBEClearside Biomedical Opens Enrollment in ODYSSEY Phase 2b..
5/11/202307:05GLOBEClearside Biomedical Announces First Quarter 2023 Financial..
5/09/202316:30GLOBEClearside Biomedical to Participate in a Fireside Chat at..
5/02/202307:05GLOBEClearside Biomedical to Report First Quarter 2023 Financial..
4/27/202307:05GLOBEClearside Biomedical Presents Compelling Data at The..
4/19/202307:05GLOBEClearside Biomedical’s Suprachoroidal Injection Platform to..
4/18/202307:05GLOBEClearside Biomedical Announces Plans for ODYSSEY Phase 2b..
4/12/202307:05GLOBEClearside Biomedical to Participate in a Fireside Chat at..
4/05/202307:05GLOBEClearside Biomedical Enhances Scientific Advisory Board with..

Your Recent History

Delayed Upgrade Clock